FI973356A0 - Angiogeneesin inhibitio käyttämällä interleukiini-12:ta - Google Patents
Angiogeneesin inhibitio käyttämällä interleukiini-12:taInfo
- Publication number
- FI973356A0 FI973356A0 FI973356A FI973356A FI973356A0 FI 973356 A0 FI973356 A0 FI 973356A0 FI 973356 A FI973356 A FI 973356A FI 973356 A FI973356 A FI 973356A FI 973356 A0 FI973356 A0 FI 973356A0
- Authority
- FI
- Finland
- Prior art keywords
- angiogenesis
- interleukin
- inhibition
- Prior art date
Links
- 102000013462 Interleukin-12 Human genes 0.000 title 1
- 108010065805 Interleukin-12 Proteins 0.000 title 1
- 229940117681 interleukin-12 Drugs 0.000 title 1
- 230000014399 negative regulation of angiogenesis Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/208—IL-12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Zoology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38938295A | 1995-02-16 | 1995-02-16 | |
| PCT/EP1996/000507 WO1996025171A1 (en) | 1995-02-16 | 1996-02-07 | Inhibition of angiogenesis using interleukin-12 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI973356A0 true FI973356A0 (fi) | 1997-08-15 |
| FI973356L FI973356L (fi) | 1997-08-15 |
Family
ID=23538033
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI973356A FI973356L (fi) | 1995-02-16 | 1997-08-15 | Angiogeneesin inhibitio käyttämällä interleukiini-12:ta |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0809511A1 (fi) |
| JP (1) | JPH11500119A (fi) |
| AU (1) | AU4788396A (fi) |
| BR (1) | BR9607427A (fi) |
| CA (1) | CA2212370A1 (fi) |
| FI (1) | FI973356L (fi) |
| TR (1) | TR199700801T1 (fi) |
| WO (1) | WO1996025171A1 (fi) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998022129A1 (fr) * | 1996-11-22 | 1998-05-28 | Toray Industries, Inc. | Agent therapeutique pour maladies ophtalmiques |
| US5858991A (en) | 1997-01-29 | 1999-01-12 | Vanderbilt University | Facilitation of wound healing with CM101/GBS toxin |
| US5981508A (en) * | 1997-01-29 | 1999-11-09 | Vanderbilt University | Facilitation of repair of neural injury with CM101/GBS toxin |
| US6028060A (en) * | 1997-01-29 | 2000-02-22 | Vanderbilt University | Treatment of chronic inflammatory diseases with CM101/GBS toxin |
| US6670337B1 (en) | 1998-01-29 | 2003-12-30 | Yeda Reaearch And Development Co., Ltd. | Facilitation of wound healing with CM101/GBS toxin |
| US6660258B1 (en) | 1997-05-09 | 2003-12-09 | Pharma Pacific Pty Ltd | Oromucosal cytokine compositions and uses thereof |
| WO1998053835A1 (en) * | 1997-05-27 | 1998-12-03 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer |
| EP1030681A4 (en) * | 1997-11-03 | 2001-07-04 | Wistar Inst | METHOD AND COMPOSITIONS FOR INHIBITING ANGIOGENESIS AND TREATING CANCER |
| EP1373206B1 (en) | 2001-03-29 | 2008-12-24 | Schering Corporation | Aryl oxime-piperazines useful as ccr5 antagonists |
| AU2003292838A1 (en) * | 2002-12-27 | 2004-07-29 | Kirin Beer Kabushiki Kaisha | Therapeutic agent for wet age-related macular degeneration |
| MXPA05010081A (es) | 2003-03-24 | 2005-11-23 | Hoffmann La Roche | Bencil-piridazinonas como inhibidores de transcriptasa inversa. |
| WO2007045573A1 (en) | 2005-10-19 | 2007-04-26 | F. Hoffmann-La Roche Ag | Phenyl-acetamide nnrt inhibitors |
| KR101401811B1 (ko) | 2006-08-16 | 2014-05-29 | 에프. 호프만-라 로슈 아게 | 비-뉴클레오사이드 역전사효소 저해제 |
| ES2550152T3 (es) | 2006-12-13 | 2015-11-04 | F. Hoffmann-La Roche Ag | Derivados de 2-(piperidin-4-il)-4-fenoxi-o fenilamino-pirimidina como inhibidores no nucleósidos de transcriptasa inversa |
| CN109789187A (zh) * | 2016-07-18 | 2019-05-21 | 创新疗法医药有限公司 | Il-12作为替代免疫治疗剂的用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0576669A4 (en) * | 1992-01-16 | 1996-05-08 | Repligen Corp | Novel methods and compositions for treatment of angiogenic diseases |
| JPH06157344A (ja) * | 1992-02-07 | 1994-06-03 | Childrens Medical Center Corp:The | 血管新生阻害のための医薬製剤及び血管新生阻害方法 |
-
1996
- 1996-02-07 CA CA002212370A patent/CA2212370A1/en not_active Abandoned
- 1996-02-07 WO PCT/EP1996/000507 patent/WO1996025171A1/en not_active Application Discontinuation
- 1996-02-07 TR TR97/00801T patent/TR199700801T1/xx unknown
- 1996-02-07 JP JP8524631A patent/JPH11500119A/ja active Pending
- 1996-02-07 EP EP96904008A patent/EP0809511A1/en not_active Withdrawn
- 1996-02-07 BR BR9607427A patent/BR9607427A/pt not_active Application Discontinuation
- 1996-02-07 AU AU47883/96A patent/AU4788396A/en not_active Abandoned
-
1997
- 1997-08-15 FI FI973356A patent/FI973356L/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1996025171A1 (en) | 1996-08-22 |
| FI973356L (fi) | 1997-08-15 |
| JPH11500119A (ja) | 1999-01-06 |
| AU4788396A (en) | 1996-09-04 |
| TR199700801T1 (tr) | 1998-03-21 |
| MX9706188A (es) | 1997-11-29 |
| BR9607427A (pt) | 1998-06-23 |
| CA2212370A1 (en) | 1996-08-22 |
| EP0809511A1 (en) | 1997-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE230389T1 (de) | Angiogenese inhibitoren | |
| NO986052D0 (no) | Antikonvulsive derivater for behandling av fedme | |
| EE03354B1 (et) | Asendatud sulfoksiidide sünteesi protsess | |
| PL322277A1 (en) | Derivatives of pyrazol-4-ylobenzoyl | |
| BR9612465A (pt) | Compostos heterocíclicos | |
| DE69621066D1 (de) | Bohrloch-Zementierungswerkzeug | |
| BR9609797A (pt) | Inibição de expressão de gene | |
| FI973356A0 (fi) | Angiogeneesin inhibitio käyttämällä interleukiini-12:ta | |
| DK0815348T3 (da) | Hydrathæmning | |
| PL324451A1 (en) | Derivatives of diphenylmethylenepiperidine | |
| BR9609726A (pt) | Inibição de expressão de gene | |
| HUP9602510A1 (en) | Preparation of substituted thiazoles | |
| DK0815341T3 (da) | Dobbelt borehulsstigrør | |
| GB9621852D0 (en) | Inhibition of scale | |
| BR9607046A (pt) | Derivados de 3-pirrolidiliden-2-ona-cefalosporinas | |
| NO980862D0 (no) | Zwitterinoformer av trovafloxacin | |
| GB9510563D0 (en) | Well inhibition | |
| IS4339A (is) | Hömlun ljóssundurliðunar á 3-setnum-2-oxindólum | |
| KR970009863U (ko) | 샤워기 걸이대 | |
| GB2305172B (en) | Preparation of substituted thiazoles | |
| KR950024188U (ko) | 갈치주낚용 도래의 고정구 | |
| GB9515060D0 (en) | Therapeutic heterocyclic compounds | |
| PT761766E (pt) | Compostos assimetricos de trifenilenodioxazina | |
| GB9521509D0 (en) | Inhibition of scale | |
| FI955924A0 (fi) | Rengoering av skivvaermevaexlare med effektultraljud |